Italfarmaco S.A.

Form 483 issued September 15, 2023 · Alcobendas, Spain

Inspection
Sep 11 – Sep 15, 2023
Investigator
Samir C. Gala
Observations
1
Pages
2
FEI number
3007048260

In short: On September 15, 2023, FDA issued a Form 483 with 1 observation to Italfarmaco S.A. in Alcobendas, Madrid (FEI 3007048260) after an inspection that ran Sep 11 – Sep 15, 2023. The investigator was Samir C. Gala. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.22 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Italfarmaco S.A.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Italfarmaco S.A.?

Samir C. Gala is named on this Form 483, for the inspection of Sep 11 – Sep 15, 2023. Each investigator has a profile showing what they cite most.

When was Italfarmaco S.A. inspected by FDA?

The inspection ran Sep 11 – Sep 15, 2023, and the Form 483 is dated September 15, 2023.

How do I get the full Form 483 for Italfarmaco S.A.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free